Sandler, Alan
Genentech, Inc,
United States
2024 Rank: 10945
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 489 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10945 | 12722 |
| Total Cites | 40560 | 42434 |
| H-index | 69 | 70 |
| Hm-index | 25 | 25 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 370 | 376 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 7269 | 7462 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 10604 | 10939 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 28855 | 29699 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.43 |
| Self-Citation Percentage |
4.42%
|
|
Sandler, Alan
Genentech, Inc,
United States
2023 Rank: 10325
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 467 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10325 | 12020 |
| Total Cites | 37196 | 38974 |
| H-index | 68 | 69 |
| Hm-index | 24 | 25 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 361 | 367 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 7103 | 7296 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 10355 | 10687 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 26532 | 27348 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.43 |
| Self-Citation Percentage |
4.56%
|
|
Sandler, Alan
Genentech Incorporated,
United States
2022 Rank: 9815
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 451 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9815 | 11550 |
| Total Cites | 33281 | 34964 |
| H-index | 65 | 67 |
| Hm-index | 24 | 24 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 352 | 358 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 6847 | 7039 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 9945 | 10272 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 23942 | 24719 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.41 |
| Self-Citation Percentage |
4.81%
|
|
Sandler, Alan
Genentech Incorporated,
United States
2021 Rank: 9398
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 431 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9398 | 11212 |
| Total Cites | 31311 | 32915 |
| H-index | 65 | 66 |
| Hm-index | 24 | 24 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 346 | 352 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 6671 | 6861 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 9674 | 9997 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 22671 | 23428 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.40 |
| Self-Citation Percentage |
4.87%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.